OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines

Publisher： Elsevier

ISSN： 1471-4906

Source： Trends in Immunology, Vol.23, Iss.2, 2002-02, pp. : 102-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

By Hombach Andreas A Abken Hinrich

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 677-681

Future Medicine

Access to resources Recommend Favorite

Targeted cytokines for cancer immunotherapy

By Lode Holger Reisfeld Ralph

Immunologic Research, Vol. 21, Iss. 2-3, 2000-06 ,pp. : 279-288

Humana Press, Inc

Access to resources Recommend Favorite

Macrophage-targeted killing and vaccines

By Guyre C.A. Fanger M.W.

Research in Immunology, Vol. 149, Iss. 7, 1998-09 ,pp. : 655-660

Elsevier

Access to resources Recommend Favorite

Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies

By Kalinski Pawel Muthuswamy Ravikumar Urban Julie

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 285-295

Informa Healthcare

Access to resources Recommend Favorite

The role of GM-CSF in enhancing immunotherapy of cancer

By Thorne Steve H

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 817-819

Future Medicine

Access to resources Recommend Favorite